ArticleCureus2025
Effectiveness of Split-Thickness Skin Grafting in Nonhealing Ulcers: Impact of Patient Demographics, Comorbidities, and Ulcer Etiology.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Early Outcomes and Complications of Skin Graft Reconstruction for Complex Wounds at a Tertiary Hospital: A Single-Centre Study in Oman.Diseases (Basel, Switzerland) · 2026Article
- Maturation of Elasticity, Pliability and Colour of Thin Split-Thickness Skin Grafts on Deep Dermal and Muscular Wound Bed Within the Course of 1 Year.International wound journal · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe primary aim of the present study was to evaluate the outcomes of split-thickness skin grafting (STSG) in the management of nonhealing ulcers. The secondary aim was to assess the impact of demographic factors, comorbidities, and ulcer etiology on graft take and overall healing outcomes. METHODOLOGY: This longitudinal, cross-sectional study was conducted in the Department of General Surgery, Shivamogga Institute of Medical Sciences, Karnataka, India, between January 2021 and December 2023. Patients aged 20-60 years with nonhealing ulcers of more than three weeks' duration and without uncontrolled systemic illness were included. The calculated sample size was 80, of whom 52 underwent STSG and were analyzed for graft outcomes. Grafts were harvested from the thigh using standard techniques, and patients were followed for four weeks to assess healing, graft take, and complications. Data were collected using a structured proforma and analyzed with IBM SPSS Statistics for Windows, Version 20 (Released 2011; IBM Corp., Armonk, New York, United States), applying Student's t-test, one-way analysis of variance (ANOVA), and Chi-square or Fisher's exact test, with p < 0.05 considered statistically significant.
resultsIn the STSG group (N = 52), the most frequent healing durations were five weeks in 23 (28.9%) patients and six weeks in 22 (27.6%) patients, while early healing at three weeks was observed in only two (2.6%) patients. The mean healing times by wound size were 5.2 weeks for ulcers <50 cm², 4.7 weeks for 50-100 cm², and 5.9 weeks for >100 cm², with no statistically significant difference (ANOVA: F = 1.72, p = 0.19). By location, 18 (22.5%) ulcers were on the right foot, 21 (26.3%) on the right leg, 25 (31.3%) on the left foot, and 16 (20.0%) on the left leg, with mean healing times ranging from 4.6 to 5.7 weeks, also without significant difference (ANOVA: F = 1.68, p = 0.18). Age significantly influenced healing, with patients aged <40 years (50, 62.5%) showing a mean healing time of 4.6 weeks compared with 6.1 weeks in those aged >40 years (30, 37.5%) (t = 4.12, p < 0.001). Graft take was <90% in 27 (33.8%) patients, 90-99% in 26 (32.5%), and 100% in 27 (33.8%), with higher graft take associated with significantly shorter healing times (<90% vs. 90-99%: t = 5.08, p < 0.001; 90-99% vs. 100%: t = 2.12, p = 0.039; <90% vs. 100%: t = 3.25, p = 0.002).
conclusionSkin grafting provides favorable healing outcomes in chronic nonhealing ulcers, with age, wound size, and graft take percentage significantly influencing healing duration. Optimizing preoperative wound conditions may enhance graft acceptance and reduce healing time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.